EAACI guidelines: Anaphylaxis (2021 update)
Antonella Muraro(University of Padua), Graham Roberts(St Mary's Hospital), Elizabeth Angier(Northern General Hospital), Debra de Silva(UK Energy Research Centre), Hanneke N.G. Oude Elberink(University Medical Center Groningen), Knut Brockow(Technical University of Munich), Kirsten Beyer(Charité - Universitätsmedizin Berlin), Susanne Halken(University of Southern Denmark), Montserrat Fernández‐Rivas(Hospital Clínico San Carlos), Louise J. Michaelis(Great North Children's Hospital), Victòria Cardona(Vall d'Hebron Hospital Universitari), Carsten Bindslev‐Jensen(Odense University Hospital), Margitta Worm(Charité - Universitätsmedizin Berlin), Stefania Arasi(Bambino Gesù Children's Hospital), Lene H. Garvey(University of Copenhagen), Cherry Alviani(University of Southampton), Berber Vlieg‐Boerstra(OLVG), Abdelouahab Bellou(Wayne State University), Ekaterina Khaleva(University of Southampton), Lynne Regent, Carmen Riggioni(University of Toronto), Audrey DunnGalvin(University College Cork), Ángel Sánchez, Diola Bijlhout(Association of Schools of Public Health in the European Region), Britt Jensen(Odense University Hospital), Maria Beatrice Bilò(Marche Polytechnic University)
Cited by 570
Related Papers
Second symposium on the definition and management of anaphylaxis: Summary report—Second National Institute of Allergy and Infectious Disease/Food Allergy and Anaphylaxis Network symposium
|Journal of Allergy and Clinical Immunology|2006|2.3k
Two Phase 3 Trials of Dupilumab versus Placebo in Atopic Dermatitis
|New England Journal of Medicine|2016|2k